Case-Based Learning on Prioritizing Care in Patients With Advanced Multimorbidity

Abstract

Advanced multimorbidity-defined as the coexistence of two or more chronic conditions with significant disease burden-presents unique challenges in contemporary clinical practice, particularly regarding the prioritization of care. This review utilizes the case-based learning approach to explore the complexities of managing patients with advanced multimorbidity, focusing on epidemiology, pathophysiology, risk factors, clinical features, diagnostic strategies, and evidence-based management. It synthesizes emerging research, guideline recommendations, and practical strategies to optimize outcomes, minimize iatrogenic harm, and enhance patient-centered care for this high-risk population.

Introduction

Multimorbidity is increasingly prevalent in aging populations and represents a critical issue for healthcare systems globally. The simultaneous management of multiple chronic conditions often leads to polypharmacy, fragmented care, and increased risk of adverse outcomes. Case-based learning provides an effective pedagogical framework for clinicians to navigate the intricacies of prioritizing care, balancing disease-specific guidelines with individualized patient needs. This article examines the scientific underpinnings and clinical implications of prioritizing care in advanced multimorbidity, aiming to equip clinicians with practical, evidence-informed tools for real-world application.

Epidemiology / Disease Burden

Recent epidemiological data underscore the growing prevalence of multimorbidity, particularly in patients aged 65 years and older. Studies estimate that over 65% of older adults have two or more chronic conditions, with approximately 20% experiencing advanced multimorbidity characterized by high symptom burden, frequent hospitalizations, and reduced functional status. The cumulative impact of multimorbidity drives significant healthcare resource utilization, increases mortality risk, and diminishes quality of life. Notably, socioeconomic deprivation, health disparities, and limited access to coordinated care exacerbate the growing burden, necessitating system-level strategies to address these challenges.

Pathophysiology

The pathophysiology of advanced multimorbidity is multifactorial and involves complex interactions between genetic predisposition, environmental exposures, and shared pathobiological mechanisms such as chronic inflammation, neurohormonal dysregulation, and impaired organ reserve. Conditions often cluster due to overlapping risk factors and pathophysiological pathways for example, diabetes, hypertension, and chronic kidney disease commonly co-occur due to metabolic syndrome. Such clustering amplifies disease severity and complicates management, underscoring the need for mechanism-based approaches that transcend single-disease models.

Risk Factors

Risk factors for developing advanced multimorbidity include advancing age, sedentary lifestyle, unhealthy diet, tobacco use, and low socioeconomic status. Genetic susceptibility, psychosocial stressors, and limited health literacy further contribute to risk. Notably, certain populations such as those with mental health disorders, disabilities, or minority backgrounds are disproportionately affected. Early identification of at-risk individuals through systematic screening can facilitate timely intervention and potentially mitigate progression to advanced disease states.

Clinical Features

Clinicians must recognize the heterogeneous presentations of advanced multimorbidity, which may include non-specific symptoms such as fatigue, functional decline, recurrent falls, and cognitive impairment. Disease interactions may mask or modify classical presentations e.g., heart failure exacerbation may present as delirium in elderly patients with cognitive impairment. Polypharmacy and multimorbidity often result in adverse drug reactions, increased frailty, and vulnerability to acute decompensation. Comprehensive assessment, including geriatric syndromes, mental health, and social determinants, is essential for holistic care planning.

Diagnosis

Diagnosis in advanced multimorbidity requires a patient-centered, multidimensional assessment rather than a disease-centric approach. Clinical evaluation should include detailed history-taking, medication review, functional assessments, and targeted investigations tailored to individual comorbidities. The use of validated tools such as the Charlson Comorbidity Index, Clinical Frailty Scale, and Comprehensive Geriatric Assessment can aid in risk stratification and inform shared decision-making. Collaborative multidisciplinary input is often necessary to fully elucidate the interplay of conditions and guide diagnostic priorities.

Treatment & Management

Management of advanced multimorbidity demands prioritization of interventions based on patient goals, prognosis, and the relative impact of each condition. Disease-specific guidelines must be judiciously adapted, with careful attention to minimizing polypharmacy, drug-drug interactions, and treatment burden. Shared decision-making, regular medication reconciliation, deprescribing where appropriate, and non-pharmacologic interventions such as rehabilitation and psychosocial support are integral. Coordination among primary care, specialists, allied health, and community resources is vital to ensure continuity and avoid fragmentation of care.

Recent Advances / Emerging Therapies

Recent advances include the development of multimorbidity-specific care models, integration of digital health tools for remote monitoring, and risk prediction algorithms to guide individualized care plans. Personalized medicine approaches such as pharmacogenomics are being explored to optimize therapy selection and minimize adverse effects. Furthermore, multidisciplinary clinics and case management interventions have shown promise in reducing hospitalizations and improving patient-centered outcomes. Ongoing research is focused on developing robust evidence to inform multimorbidity-specific guidelines and outcome measures.

Guideline Recommendations

International guidelines increasingly emphasize the need for individualized, goal-oriented care in patients with advanced multimorbidity. The National Institute for Health and Care Excellence (NICE) and American Geriatrics Society recommend regular medication reviews, shared decision-making, and prioritization of interventions that align with patient values and preferences. Guidelines advise against rigid adherence to single-disease protocols in favor of holistic, patient-centered approaches. Emphasis is placed on optimizing function, maintaining independence, and addressing palliative needs when appropriate.

Conclusion

Prioritizing care in patients with advanced multimorbidity is a complex, dynamic process that requires integration of clinical expertise, evidence-based guidelines, and patient preferences. Case-based learning supports the development of nuanced decision-making skills, enabling clinicians to navigate the multifaceted challenges of multimorbidity. Ongoing research, interprofessional collaboration, and system-wide innovations are essential to improve outcomes and quality of life for this vulnerable population.